SUSTAINABILITY OF RESPONSE BETWEEN UPADACITINIB AND ADALIMUMAB AMONG PATIENTS WITH RHEUMATOID ARTHRITIS AND PRIOR INADEQUATE RESPONSE TO METHOTREXATE

被引：0
|
作者：
Nash, Peter [1 ]
Kavanaugh, Arthur [2 ]
Buch, Maya [3 ]
Combe, Bernard [4 ]
Bessette, Louis [5 ]
Song, In-Ho [6 ]
Song, Yanna [6 ]
Suboticki, Jessica [6 ]
Fleischmann, Roy [7 ]
机构：
[1] Griffith Univ, Brisbane, Qld, Australia
[2] Univ Calif San Diego, Sch Med, Div Rheumatol Allergy & Immunol, San Diego, CA 92103 USA
[3] Univ Manchester, Sch Biol Sci, Ctr Musculoskeletal Res, Machester, England
[4] Univ Montpellier, Montpellier, France
[5] Laval Univ, Quebec City, PQ, Canada
[6] Abbvie Inc, N Chicago, IL USA
[7] Southwestern Med Ctr, Metroplex Clin Res Ctr, Dallas, TX USA
来源：
INTERNAL MEDICINE JOURNAL | 2021年 / 51卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P107
引用
下载
收藏
页码：46 / 47
页数：2
相关论文
共 50 条
  • [1] Sustainability of Response Between Upadacitinib and Adalimumab Among Patients with Rheumatoid Arthritis and Prior Inadequate Response to Methotrexate
    Nash, Peter
    Kavanaugh, Arthur
    Buch, Maya
    Combe, Bernard
    Bessette, Louis
    Song, In-Ho
    Song, Yanna
    Suboticki, Jessica
    Fleischmann, Roy
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [2] SUSTAINABILITY OF RESPONSE BETWEEN UPADACITINIB AND ADALIMUMAB AMONG PATIENTS WITH RHEUMATOID ARTHRITIS AND PRIOR INADEQUATE RESPONSE TO METHOTREXATE
    Nash, P.
    Kavanaugh, A.
    Buch, M. H.
    Combe, B.
    Bessette, L.
    Song, I. H.
    Song, Y.
    Suboticki, J.
    Fleischmann, R.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 643 - 644
  • [3] SUSTAINABILITY OF RESPONSE TO UPADACITINIB AS MONOTHERAPY OR IN COMBINATION AMONG PATIENTS WITH RHEUMATOID ARTHRITIS AND PRIOR INADEQUATE RESPONSE TO CONVENTIONAL SYNTHETIC DMARDS
    Kavanaugh, A.
    Buch, M. H.
    Combe, B.
    Bessette, L.
    Song, I. H.
    Song, Y.
    Suboticki, J.
    Nash, P.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 323 - 324
  • [4] SUSTAINABILITY OF RESPONSE TO UPADACITINIB AS MONOTHERAPY OR IN COMBINATION AMONG PATIENTS WITH RHEUMATOID ARTHRITIS AND PRIOR INADEQUATE RESPONSE TO CONVENTIONAL SYNTHETIC DMARDS
    Kavanaugh, Arthur
    Buch, Maya
    Combe, Bernard
    Bessette, Louis
    Song, In-Ho
    Song, Yanna
    Suboticki, Jessica
    Nash, Peter
    INTERNAL MEDICINE JOURNAL, 2021, 51 : 46 - 46
  • [5] Sustainability of Response to Upadacitinib as Monotherapy or in Combination Among Patients with Rheumatoid Arthritis and Prior Inadequate Response to Conventional Synthetic DMARDs
    Kavanaugh, Arthur
    Buch, Maya
    Combe, Bernard
    Bessette, Louis
    Song, In-Ho
    Song, Yanna
    Suboticki, Jessica
    Nash, Peter
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [6] Upadacitinib as Monotherapy in Patients with Rheumatoid Arthritis and Prior Inadequate Response to Methotrexate: Results at 84 Weeks
    Smolen, Josef
    Emery, Paul
    Rigby, William
    Tanaka, Yoshiya
    Vargas, Juan
    Damjanov, Nemanja
    Jain, Manish
    Song, Yanna
    Khan, Nasser
    Enejosa, Jeffrey
    Cohen, Stanley
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [7] Upadacitinib Monotherapy Improves Patient-Reported Outcomes in Patients with Rheumatoid Arthritis and Inadequate Response to Methotrexate
    Strand, Vibeke
    Buch, Maya
    Tundia, Namita
    Camp, Heidi S.
    Suboticki, Jessica
    Goldschmidt, Debbie
    Wells, Alvin F.
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [8] UPADACITINIB AS MONOTHERAPY IN PATIENTS WITH RHEUMATOID ARTHRITIS AND PRIOR INADEQUATE RESPONSE TO METHOTREXATE: RESULTS AT 260 WEEKS FROM THE SELECT-MONOTHERAPY STUDY
    Smolen, J. S.
    Emery, P.
    Rigby, W.
    Tanaka, Y.
    Vargas, J. Ignacio
    Damjanov, N.
    Jain, M.
    Kato, K.
    Carter, K.
    Khan, N.
    Camp, H.
    Cohen, S. B.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 723 - 724
  • [9] A Phase 3, Randomized, Double-Blind Study Comparing Upadacitinib to Placebo and to Adalimumab, in Patients with Active Rheumatoid Arthritis with Inadequate Response to Methotrexate
    Fleischmann, Roy
    Pangan, Aileen L.
    Mysler, Eduardo
    Bessette, Louis
    Peterfy, Charles
    Durez, Patrick
    Ostor, Andrew
    Li, Yihan
    Zhou, Yijie
    Othman, Ahmed A.
    Song, In-Ho
    Genovese, Mark C.
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [10] UPADACITINIB AS MONOTHERAPY IN PATIENTS WITH RHEUMATOID ARTHRITIS AND PRIOR INADEQUATE RESPONSE TO METHOTREXATE: RESULTS AT 84 WEEKS FROM THE SELECT-MONOTHERAPY STUDY
    Smolen, J. S.
    Emery, P.
    Rigby, W.
    Tanaka, Y.
    Vargas, J. Ignacio
    Damjanov, N.
    Jain, M.
    Song, Y.
    Khan, N.
    Enejosa, J. J.
    Cohen, S. B.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 327 - 328
12345